ANTI DS-DNA ANTIBODY - IFA - SCREEN WITHOUT TITERS

The Anti-dsDNA (Double-Stranded DNA) Antibody Test by Indirect Immunofluorescence Assay (IFA) Screen (Without Titers) is a specialized blood test used to screen for antibodies directed against double-stranded DNA (dsDNA). These autoantibodies are highly associated with Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease that can affect the skin, joints, kidneys, heart, lungs, brain, and other organs.

This test uses the Indirect Immunofluorescence Assay (IFA) technique to determine the presence or absence of Anti-dsDNA antibodies. Unlike tests with reflex titers, this screening test provides a qualitative result only and does not measure antibody concentration (titer). It is commonly used as an initial screening test for patients with suspected lupus or positive ANA results.

Benefits of the Test

• Screens for Anti-dsDNA antibodies with high specificity.
• Supports early diagnosis of Systemic Lupus Erythematosus (SLE).
• Helps evaluate autoimmune connective tissue disorders.
• Useful for confirming suspected lupus after a positive ANA test.
• Supports early clinical decision-making.
• Uses the reliable Indirect Immunofluorescence Assay (IFA) method.

Why Doctors Recommend This Test

Doctors may recommend the Anti-dsDNA Antibody IFA Screen for patients experiencing symptoms suggestive of lupus, including:

• Persistent joint pain and swelling
• Butterfly-shaped facial rash (malar rash)
• Photosensitivity (sunlight sensitivity)
• Unexplained fever
• Chronic fatigue
• Mouth or nasal ulcers
• Hair loss
• Kidney problems such as blood or protein in urine
• Positive Antinuclear Antibody (ANA) test

This screening test is often ordered alongside ANA Profile, ENA Panel, Complement (C3 & C4), ESR, CRP, and other autoimmune investigations.

Preparation Before Test

• No fasting is required.
• Continue routine medications unless advised otherwise by your physician.
• Inform your healthcare provider about your medical history and current medications.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 3–7 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected Systemic Lupus Erythematosus (SLE).
• Patients with a positive ANA test requiring further evaluation.
• Individuals with symptoms of autoimmune connective tissue disorders.
• Patients being evaluated for autoimmune kidney disease.
• Individuals referred by rheumatologists or nephrologists.
• Patients requiring initial Anti-dsDNA antibody screening.

Patient-Friendly Summary

The Anti-dsDNA Antibody Test by IFA Screen (Without Titers) is a blood test that checks whether your immune system produces antibodies against double-stranded DNA. These antibodies are commonly found in people with Systemic Lupus Erythematosus (SLE), an autoimmune disease in which the immune system attacks healthy tissues. Symptoms of lupus may include joint pain, skin rashes, fatigue, mouth ulcers, and kidney problems. This screening test helps doctors determine whether Anti-dsDNA antibodies are present. Unlike tests with reflex titers, it does not measure antibody levels but serves as an important first step in diagnosing lupus. The test is safe, requires only a blood sample, and does not require fasting.